Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 8/20 | 0.62 |
| ▸ | MAPT | P10636 | 7/20 | 0.61 |
| ▸ | MYC | P01106 | 1/20 | 0.59 |
| ▸ | MAX | P61244 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | POLB | P06746 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.56 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | GAA | P10253 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29489945 | 1.00 | NQO2 (0.62) | NQO2MAPTMYCMAXKMT2A | |
| SCHEMBL9979780 | 0.85 | MAPT (0.46) | NQO2MAPTMYCMAXKMT2A | |
| SCHEMBL30950408 | 0.84 | MYC (0.46) | NQO2MAPTMYCMAXKMT2A | |
| SCHEMBL31484242 | 0.84 | MAPT (0.71) | NQO2MAPTMYCMAXKMT2A | |
| SCHEMBL1913858 | 0.84 | MAPT (0.71) | NQO2MAPTMYCMAXKMT2A | |
| SCHEMBL6206349 | 0.84 | NQO2 (0.71) | NQO2MAPTMYCMAXKMT2A | |
| SCHEMBL31601101 | 0.84 | MAPT (0.71) | NQO2MAPTMYCMAXKMT2A | |
| SCHEMBL21722604 | 0.83 | MYC (0.46) | NQO2MAPTMYCMAXKMT2A | |
| SCHEMBL13156546 | 0.82 | MAPT (0.79) | NQO2MAPTMYCMAXKMT2A | |
| SCHEMBL4612924 | 0.82 | MAPT (0.79) | NQO2MAPTMYCMAXKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024196860-A2 | SEPARATION DEVICES, SYSTEMS AND METHODS FOR REMOVAL OF CARBON DIOXIDE IN DESALINATION PROCESSES | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-09-26 | — | — | WO | claimed |
| CN-113061118-B | Phenazine-chalcone hybrid compound and preparation method and application thereof | 株洲九派科技发展有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-113061118-A | Phenazine-chalcone hybrid compound and preparation method and application thereof | 广州格瑞科技发展有限公司 | 2021-07-02 | — | — | CN | claimed |
| US-20250263384-A9 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | CMBLU ENERGY AG (DE) | 2025-08-21 | — | — | US | disclosed |
| US-20250228880-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-07-17 | — | — | US | disclosed |
| WO-2024196860-A2 | SEPARATION DEVICES, SYSTEMS AND METHODS FOR REMOVAL OF CARBON DIOXIDE IN DESALINATION PROCESSES | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-09-26 | — | — | WO | disclosed |
| US-20240243319-A1 | AQUEOUS ELECTROLYTE, SALTS USED THEREIN, AND REDOX FLOW BATTERY USING SAID AQUEOUS ELECTROLYTE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240222674-A1 | Aqueous Energy Storage System For Redox Flow Batteries | CMBLU ENERGY AG (DE) | 2024-07-04 | — | — | US | disclosed |
| US-20240124405-A1 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | CMBLU PROJECKT AG (DE) | 2024-04-18 | — | — | US | disclosed |
| CN-114497539-B | Aqueous rechargeable battery based on copper ferrocyanide anode and phenazine organic matter cathode | 常州大学 | 2024-01-23 | — | — | CN | disclosed |
| US-20230411662-A1 | Electrolyte Regeneration for Organic Redox Flow Batteries Based on Water-Soluble Phenzaine-Based Compounds | CMBLU ENERGY AG (DE) | 2023-12-21 | — | — | US | disclosed |
| WO-2011117830-A1 | DERIVATIVES OF PHENAZINE USEFUL TO TREAT CANCER | Université de la Méditerranée AIX-Marseille II (FR) | 2011-09-29 | — | — | WO | disclosed |
| EP-2368885-A1 | Derivatives of phenazine useful to treat cancer | Université de la Méditerranée (Aix-Marseille II) (FR) | 2011-09-28 | — | — | EP | disclosed |
| EP-2368885-A1 | Derivatives of phenazine useful to treat cancer | Université de la Méditerranée (Aix-Marseille II) (FR) | 2011-09-28 | — | — | EP | disclosed |
| US-20100124554-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2010-05-20 | — | — | US | disclosed |
| EP-2078720-A1 | Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained and uses thereof | Université de la Méditerranée - Aix-Marseille II (FR) | 2009-07-15 | — | — | EP | disclosed |
| WO-2009083532-A2 | NOVEL METHOD FOR THE PREPARATION OF DERIVATIVES OF DIHYDROTETRAAZAPENTACENES, PRODUCTS SUCH AS OBTAINED, AND USES THEREOF | UNIVERSITE DE LA MEDITERRANEE AIX-MARSEILLE II (FR) | 2009-07-09 | — | — | WO | disclosed |
| EP-0300480-B1 | Biaxially oriented polyoxymethylene film | ASAHI CHEMICAL IND (JP) | 1993-12-15 | — | — | EP | disclosed |
| US-4946930-A | ISOTHERMALLY RECRYSTALLIZED FILM WITH SPHERULITES AT ITS SURFACE; SMOOTHNESS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1990-08-07 | — | — | US | disclosed |
| EP-0300480-A2 | Biaxially oriented polyoxymethylene film | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1989-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228880-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | TXN2, SQOR, LPO | NQO2 528/4885MAPT 2622/4885MYC 797/4885 |
| US-20100124554-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | TXN2, SQOR, LPO | NQO2 528/4885MAPT 2622/4885MYC 797/4885 |
| US-20240124405-A1 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | NOX4, NQO1, GPX1 | NQO2 519/4885MAPT 1567/4885MYC 3467/4885 |
| US-20250263384-A9 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | NOX4, NQO1, GPX1 | NQO2 519/4885MAPT 1567/4885MYC 3467/4885 |
| US-20230411662-A1 | Electrolyte Regeneration for Organic Redox Flow Batteries Based on Water-Soluble Phenzaine-Based Compounds | SLC6A12, POF1B, GPX4 | NQO2 1788/4885MAPT 2869/4885MYC 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.